Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 23925044)

1.

Serum decoy receptor 3 is a useful predictor for the active status of chronic hepatitis B in hepatitis B e antigen-negative patients.

Hou Y, Xu P, Lou X, Liang D, Zhang M, Zhang Z, Zhang L.

Tohoku J Exp Med. 2013;230(4):227-32.

2.

Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ.

Hepatology. 2007 Oct;46(4):1057-70.

PMID:
17654702
3.

Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.

Diang XC, Ma LN, Li YF, Liu XY, Zhang X, Liu JY, Sheng YJ, Zhang DZ, Hu HD, Ren H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2357-60.

PMID:
22688015
4.

Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.

Han Y, Tang Q, Zhu W, Zhang X, You L.

J Gastroenterol Hepatol. 2008 Nov;23(11):1728-33. doi: 10.1111/j.1440-1746.2008.05600.x. Epub 2008 Sep 24.

PMID:
18823435
5.

Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.

Li C, Ji H, Cai Y, Ayana DA, Lv P, Liu M, Jiang Y.

J Interferon Cytokine Res. 2013 Oct;33(10):612-8. doi: 10.1089/jir.2013.0001. Epub 2013 May 22.

6.

[Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].

Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.

Taehan Kan Hakhoe Chi. 2003 Dec;9(4):284-92. Korean.

7.

Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.

Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

Gastroenterology. 2009 Feb;136(2):505-12. doi: 10.1053/j.gastro.2008.10.089. Epub 2008 Nov 27.

PMID:
19101558
8.

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.

Park H, Lee JM, Seo JH, Kim HS, Ahn SH, Kim do Y, Han KH, Chon CY, Park JY.

Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30.

PMID:
22128792
9.

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.

J Viral Hepat. 2008 Jun;15(6):434-41. doi: 10.1111/j.1365-2893.2007.00957.x. Epub 2008 Jan 9.

PMID:
18194171
10.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
11.

Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.

Bae CB, Kim SS, Ahn SJ, Cho HJ, Kim SR, Park SY, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Shin SJ, Cho SW, Cheong JY.

J Clin Virol. 2013 Dec;58(4):641-6. doi: 10.1016/j.jcv.2013.10.008. Epub 2013 Oct 17.

PMID:
24210327
12.

Distinct seromarkers predict different milestones of chronic hepatitis B progression.

Liu J, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Hsiao CK, Chen CJ; REVEAL-HBV Study Group.

Hepatology. 2014 Jul;60(1):77-86. doi: 10.1002/hep.27083. Epub 2014 May 28.

PMID:
24700432
13.

Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.

Ramachandran J, Ismail AM, Chawla G, Fletcher GJ, Goel A, Eapen CE, Abraham P.

Indian J Gastroenterol. 2014 Mar;33(2):131-5. doi: 10.1007/s12664-013-0395-1. Epub 2013 Sep 20.

PMID:
24052375
14.

Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.

Assy N, Beniashvili Z, Djibre A, Nasser G, Grosovski M, Nseir W.

World J Gastroenterol. 2009 Jun 28;15(24):3025-31.

15.

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.

PMID:
21672542
16.

Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.

Atay AE, Seven G, Yalcin K, Pasa S, Degertekin H.

J Int Med Res. 2012;40(5):1891-6.

PMID:
23206472
17.

Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.

Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, Allende H, Martell M, Esteban R, Guardia J.

J Viral Hepat. 2006 May;13(5):343-50.

PMID:
16637866
18.

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.

Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.

Hepatology. 2010 Jun;51(6):1933-44. doi: 10.1002/hep.23571.

PMID:
20512987
19.

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.

Martinot-Peignoux M, Carvalho-Filho R, Lapalus M, Netto-Cardoso AC, Lada O, Batrla R, Krause F, Asselah T, Marcellin P.

J Hepatol. 2013 Jun;58(6):1089-95. doi: 10.1016/j.jhep.2013.01.028. Epub 2013 Jan 28.

PMID:
23369792
20.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk